Insiders Verastem, Inc.

Equities

VSTM

US92337C2035

Market Closed - Nasdaq Other stock markets 21:00:00 13/05/2024 BST			5-day change	1st Jan Change
12.02 ^USD	+1.43%		+1.52%	+47.67%

05-09	Verastem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-18	Verastem Names John Hayslip as Chief Medical Officer	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Verastem Names John Hayslip as Chief Medical Officer	04-18	MT
Verastem Oncology Announces Executive Changes	04-18	CI
Verastem Promotes Vice President of Finance Dan Calkins to CFO	27/10/23	MT
Verastem Oncology Announces Executive Appointments	26/10/23	CI
Verastem, Inc. Appoints Daniel Paterson as Class III Director	12/07/23	CI
Verastem Promotes President Dan Paterson to Chief Executive	11/07/23	MT
Verastem Oncology Announces Chief Executive Officer Changes, Effective August 1, 2023	11/07/23	CI
-Verastem Oncology Appoints Karin Tollefson to Board of Directors	17/05/23	CI
Bivictrix promotes non-executive director to non-executive chair	06/01/23	AN
Verastem Oncology Appoints of Robert Gagnon to its Board of Directors	15/12/22	CI
Verastem Oncology Appoints Rob Gagnon to the Board of Directors	15/12/22	CI
Verastem Oncology Appoints Anil Kapur to Board of Directors	20/10/22	CI
Verastem Chief Financial Officer to Resign	30/09/22	MT
Verastem, Inc. Announces Resignation of Robert Gagnon as Chief Business and Financial Officer, Effective October 31, 2022	30/09/22	CI
Verastem, Inc. Announces Resignation of Robert Gagnon as Chief Business and Financial Officer, Effective October 31, 2022	30/09/22	CI
Verastem, Inc. Announces Management Changes	28/03/22	CI
Verastem Oncology Appoints Channing Der to Its Scientific Advisory Board	24/03/22	CI
Verastem Oncology Appoints Michelle Robertson to Board of Directors, Effective November 15, 2021	26/10/21	CI
Verastem Oncology Reports the Appointment of Louis J. Denis as Chief Medical Officer	30/09/21	CI
Verastem : Oncology Names Louis Denis Chief Medical Officer	22/09/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Verastem, Inc.

Equities

VSTM

US92337C2035

Insiders

Filters